Solara Active Pharma Science - Emerging As Large Player In Pure API Business: ICICI Securities
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Solara Active Pharma Science Ltd. is emerging as a large-scale player in pure active pharmaceutical ingredient segment with a large product portfolio and presence across developed and emerging markets.
Company was formed by combining the demerged human API businesses of Strides Pharma Science Ltd. and Sequent Scientific Ltd. in FY18.
Key moats of the company have been:
1. presence only in the API and contract research manufacturing service space thereby removing any potential conflict with clients,
2. maintaining large market share in key products,
3. long term business relationships with customers, and
4. strong regulatory track record.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.